Published in J Clin Endocrinol Metab on April 01, 1999
Early expression of antiinsulin autoantibodies of humans and the NOD mouse: evidence for early determination of subsequent diabetes. Proc Natl Acad Sci U S A (2000) 3.89
Mature high-affinity immune responses to (pro)insulin anticipate the autoimmune cascade that leads to type 1 diabetes. J Clin Invest (2004) 2.34
Prediction and pathogenesis in type 1 diabetes. Immunity (2010) 2.26
Primary dietary intervention study to reduce the risk of islet autoimmunity in children at increased risk for type 1 diabetes: the BABYDIET study. Diabetes Care (2011) 1.38
Pregnancy induces nonimmunoglobulin insulin-binding activity in both maternal and cord blood serum. Clin Exp Immunol (2001) 0.85
German new onset diabetes in the young incident cohort study: DiMelli study design and first-year results. Rev Diabet Stud (2010) 0.84
Epitope analysis of insulin autoantibodies using recombinant Fab. Clin Exp Immunol (2005) 0.82
Etiopathogenesis of insulin autoimmunity. Anat Res Int (2012) 0.79
Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study. Diabetes (1999) 3.00
Novel organ-specific circulating cardiac autoantibodies in dilated cardiomyopathy. J Am Coll Cardiol (1990) 2.67
Prediction of IDDM in the general population: strategies based on combinations of autoantibody markers. Diabetes (1997) 2.65
Four-year metabolic outcome of a randomised controlled CD3-antibody trial in recent-onset type 1 diabetic patients depends on their age and baseline residual beta cell mass. Diabetologia (2010) 2.65
Diabetes Antibody Standardization Program: evaluation of assays for autoantibodies to glutamic acid decarboxylase and islet antigen-2. Diabetologia (2008) 2.51
Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop. Diabetes (1998) 2.38
No association of antibodies to glutamic acid decarboxylase and diabetic complications in patients with IDDM. Diabetes Care (1995) 2.14
Similar low frequency of anti-MOG IgG and IgM in MS patients and healthy subjects. Neurology (2004) 2.04
Pattern of month of birth in diabetic and non-diabetic adults. Isr Med Assoc J (2002) 2.03
Autoantibodies to zinc transporter 8 and SLC30A8 genotype stratify type 1 diabetes risk. Diabetologia (2009) 2.00
A novel micro-assay for insulin autoantibodies. J Autoimmun (1997) 1.90
Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives. Diabetes (1994) 1.82
Age-related islet autoantibody incidence in offspring of patients with type 1 diabetes. Diabetologia (2012) 1.81
Autoantibodies to glutamic acid decarboxylase in palatal myoclonus and epilepsy. Ann Neurol (1994) 1.72
Comparison of tissue transglutaminase-specific antibody assays with established antibody measurements for coeliac disease. J Autoimmun (1999) 1.70
Capillary whole blood measurement of islet autoantibodies. Diabetes Care (1999) 1.66
Islet isolation for allotransplantation: variables associated with successful islet yield and graft function. Diabetologia (2005) 1.62
Beta cell function during rapamycin monotherapy in long-term type 1 diabetes. Diabetologia (2010) 1.60
Diabetes Antibody Standardization Program: evaluation of assays for insulin autoantibodies. Diabetologia (2010) 1.57
Antibodies to tissue transglutaminase C in type I diabetes. Diabetologia (1999) 1.57
Chagas disease in Italy: breaking an epidemiological silence. Euro Surveill (2011) 1.44
Antibodies to bovine serum albumin (BSA) in type 1 diabetes and other autoimmune disorders. Exp Clin Endocrinol Diabetes (1997) 1.43
IDDM2/insulin VNTR modifies risk conferred by IDDM1/HLA for development of Type 1 diabetes and associated autoimmunity. Diabetologia (2003) 1.37
Transmission ratio distortion at the INS-IGF2 VNTR. Nat Genet (1999) 1.34
Early autoantibody responses in prediabetes are IgG1 dominated and suggest antigen-specific regulation. J Immunol (1999) 1.29
Concentration of insulin autoantibodies at onset of type I diabetes. Inverse log-linear correlation with age. Diabetes Care (1988) 1.27
Autoantibody response to islet transplantation in type 1 diabetes. Diabetes (2001) 1.26
Autoantibodies to IA-2beta improve diabetes risk assessment in high-risk relatives. Diabetologia (2008) 1.25
Development of celiac disease-associated antibodies in offspring of parents with type I diabetes. Diabetologia (2000) 1.23
Natural course of remission in IDDM during 1st yr after diagnosis. Diabetes Care (1992) 1.21
IA-2 antibodies--a sensitive marker of IDDM with clinical onset in childhood and adolescence. Childhood Diabetes in Finland Study Group. Diabetologia (1998) 1.21
Breastfeeding habits in families with Type 1 diabetes. Diabet Med (2007) 1.20
Antibodies to islet 37k antigen, but not to glutamate decarboxylase, discriminate rapid progression to IDDM in endocrine autoimmunity. Diabetes (1994) 1.19
Early development and spreading of autoantibodies to epitopes of IA-2 and their association with progression to type 1 diabetes. J Immunol (1998) 1.19
Can we really predict IDDM? Diabetes (1993) 1.18
Risk of type 1 diabetes development in children with incidental hyperglycemia: A multicenter Italian study. Diabetes Care (2001) 1.17
Parameters associated with residual insulin secretion during the first year of disease in children and adolescents with Type 1 diabetes mellitus. Diabet Med (1998) 1.16
No major association of breast-feeding, vaccinations, and childhood viral diseases with early islet autoimmunity in the German BABYDIAB Study. Diabetes Care (2000) 1.15
Identification of naturally processed T cell epitopes from glutamic acid decarboxylase presented in the context of HLA-DR alleles by T lymphocytes of recent onset IDDM patients. J Clin Invest (1997) 1.14
Cellular immune response to diverse islet cell antigens in IDDM. Diabetes (1996) 1.11
Proposed guidelines on screening for risk of type 1 diabetes. Diabetes Care (2001) 1.11
Prediction of type 1 diabetes postpartum in patients with gestational diabetes mellitus by combined islet cell autoantibody screening: a prospective multicenter study. Diabetes (1997) 1.10
Comparison of a novel micro-assay for insulin autoantibodies with the conventional radiobinding assay. Diabetologia (1998) 1.10
No evidence for an association of coxsackie virus infections during pregnancy and early childhood with development of islet autoantibodies in offspring of mothers or fathers with type 1 diabetes. J Autoimmun (2001) 1.09
Characterization of insulin autoantibodies in relatives of patients with type I diabetes. Diabetes (1993) 1.09
Ghrelin-producing epsilon cells in the developing and adult human pancreas. Diabetologia (2008) 1.09
Modulation of humoral islet autoimmunity by pancreas allotransplantation influences allograft outcome in patients with type 1 diabetes. Diabetes (2000) 1.07
Development of autoimmunity to transglutaminase C in children of patients with type 1 diabetes: relationship to islet autoantibodies and infant feeding. Diabetologia (2006) 1.07
BABYDIET, a feasibility study to prevent the appearance of islet autoantibodies in relatives of patients with Type 1 diabetes by delaying exposure to gluten. Diabetologia (2004) 1.05
Lack of immunohistological changes in the islets of nondiabetic, autoimmune, polyendocrine patients with beta-selective GAD-specific islet cell antibodies. Diabetes (1994) 1.03
Type 1 diabetes risk assessment: improvement by follow-up measurements in young islet autoantibody-positive relatives. Diabetologia (2006) 1.03
High level of concordance between assays for glutamic acid decarboxylase antibodies. The First International Glutamic Acid Decarboxylase Antibody Workshop. Diabetes (1994) 1.03
Autoantibodies in insulin-dependent diabetes recognize distinct cytoplasmic domains of the protein tyrosine phosphatase-like IA-2 autoantigen. J Immunol (1996) 1.03
Early expression and high prevalence of islet autoantibodies for DR3/4 heterozygous and DR4/4 homozygous offspring of parents with Type I diabetes: the German BABYDIAB study. Diabetologia (1999) 1.03
Association of IA-2 autoantibodies with HLA DR4 phenotypes in IDDM. Diabetologia (1996) 1.02
Maturation of the humoral autoimmune response to epitopes of GAD in preclinical childhood type 1 diabetes. Diabetes (2000) 1.01
IA-2 antibody prevalence and risk assessment of early insulin requirement in subjects presenting with type 2 diabetes (UKPDS 71). Diabetologia (2005) 1.01
Genetic association of zinc transporter 8 (ZnT8) autoantibodies in type 1 diabetes cases. Diabetologia (2012) 1.00
GAD autoantibodies and epitope reactivities persist after diagnosis in latent autoimmune diabetes in adults but do not predict disease progression: UKPDS 77. Diabetologia (2007) 0.99
A strategy for combining minor genetic susceptibility genes to improve prediction of disease in type 1 diabetes. Genes Immun (2012) 0.99
GADIA2-combi determination as first-line screening for improved prediction of type 1 diabetes in relatives. Diabetes (1998) 0.98
Psychological impact of childhood islet autoantibody testing in families participating in the BABYDIAB study. Diabet Med (2004) 0.98
Evaluation of islet cell antigen (ICA) 512/IA-2 autoantibody radioassays using overlapping ICA512/IA-2 constructs. J Clin Endocrinol Metab (1997) 0.97
Characteristics of rapid vs slow progression to type 1 diabetes in multiple islet autoantibody-positive children. Diabetologia (2013) 0.96
Distinct cytoplasmic islet cell antibodies with different risks for type 1 (insulin-dependent) diabetes mellitus. Diabetologia (1992) 0.96
In insulin-autoantibody-positive children from the general population, antibody affinity identifies those at high and low risk. Diabetologia (2005) 0.96
Disease sensitivity and specificity of 52 assays for glutamic acid decarboxylase antibodies. The Second International GADAB Workshop. Diabetes (1995) 0.96
The second International Workshop on the Standardisation of Insulin Autoantibody (IAA) measurement. Held in New York, 27-30 October 1987. Diabetologia (1988) 0.95
Immunomagnetic isolation of CD4+CD25+FoxP3+ natural T regulatory lymphocytes for clinical applications. Clin Exp Immunol (2009) 0.94
Changes of vitamin D3 serum concentrations at the onset of immune-mediated type 1 (insulin-dependent) diabetes mellitus. Diabetes Res (1991) 0.94
An update on preventive and regenerative therapies in diabetes mellitus. Pharmacol Ther (2008) 0.94
Sera from patients with IDDM and healthy individuals have antibodies to ICA69 on western blots but do not immunoprecipitate liquid phase antigen. J Autoimmun (1994) 0.92
Prevalence, characteristics and diabetes risk associated with transient maternally acquired islet antibodies and persistent islet antibodies in offspring of parents with type 1 diabetes. J Clin Endocrinol Metab (2001) 0.92
[Breastfeeding in women with gestational diabetes]. Dtsch Med Wochenschr (2008) 0.92
Validity of screening for individuals at risk for type I diabetes by combined analysis of antibodies to recombinant proteins. Diabetes Care (1997) 0.92
Expression of the protein tyrosine phosphatase-like protein IA-2 during pancreatic islet development. J Histochem Cytochem (2001) 0.91
Inappropriate major histocompatibility complex expression on cardiac tissue in dilated cardiomyopathy. Relevance for autoimmunity? J Autoimmun (1990) 0.91
Low prevalence of islet autoimmunity in adult diabetes and low predictive value of islet autoantibodies in the general adult population of northern Italy. Diabetologia (1999) 0.90
Antinuclear antibody. Precise and accurate quantitation without serial dilution. J Immunol Methods (1986) 0.90
Can islet cell antibodies predict IDDM in the general population? Diabetes Care (1993) 0.90
Association of immune mediators at diagnosis of Type 1 diabetes with later clinical remission. Diabet Med (2007) 0.89
Delay of type I diabetes in high risk, first degree relatives by parenteral antigen administration: the Schwabing Insulin Prophylaxis Pilot Trial. Diabetologia (1998) 0.89
Islet cell and thyroid antibody prevalence in patients with hepatitis C virus infection: effect of treatment with interferon. J Lab Clin Med (2001) 0.89
Is islet autoimmunity related to insulin sensitivity or body weight in children of parents with type 1 diabetes? Diabetologia (2009) 0.89
High-dose intravenous insulin infusion versus intensive insulin treatment in newly diagnosed IDDM. Diabetes (1997) 0.88
Early infant diet in children at high risk for type 1 diabetes. Horm Metab Res (2009) 0.88
Perinatal autoimmunity in offspring of diabetic parents. The German Multicenter BABY-DIAB study: detection of humoral immune responses to islet antigens in early childhood. Diabetes (1996) 0.88